{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:17:33Z","timestamp":1792264653191,"version":"4.4.0"},"reference-count":49,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2021,11,1]]},"DOI":"10.1001\/jamadermatol.2021.3676","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T12:44:10Z","timestamp":1632919450000},"page":"1335","source":"Crossref","is-referenced-by-count":43,"title":["Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors"],"prefix":"10.1001","volume":"157","author":[{"given":"Bevin","family":"Bhoyrul","sequence":"first","affiliation":[{"name":"Sinclair Dermatology, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Asfour","sequence":"additional","affiliation":[{"name":"The Dermatology Centre, Salford Royal National Health Service Foundation Trust, Salford, Greater Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Lutz","sequence":"additional","affiliation":[{"name":"Hair and Nail Medicine, Bonn, Germany"},{"name":"Department of Dermatology and Allergy, University Hospital of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorne","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Alan Lyell Centre for Dermatology, Queen Elizabeth University Hospital, Glasgow, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekka","family":"Jerjen","sequence":"additional","affiliation":[{"name":"Sinclair Dermatology, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney D.","family":"Sinclair","sequence":"additional","affiliation":[{"name":"Sinclair Dermatology, Melbourne, Australia"},{"name":"University of Melbourne, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Holmes","sequence":"additional","affiliation":[{"name":"Alan Lyell Centre for Dermatology, Queen Elizabeth University Hospital, Glasgow, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iskander H.","family":"Chaudhry","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Royal Liverpool and Broadgreen University Hospitals National Health Service Trust, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Harries","sequence":"additional","affiliation":[{"name":"The Dermatology Centre, Salford Royal National Health Service Foundation Trust, Salford, Greater Manchester, United Kingdom"},{"name":"Centre for Dermatology Research, University of Manchester, Manchester Academic Health Science Centre  and National Institute for Health Research Manchester Biomedical Research Centre, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"doi210052r1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.v68.6","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"7261","key":"doi210052r2","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/bmj.321.7261.624","article-title":"ABC of breast diseases: breast cancer\u2014epidemiology, risk factors, and genetics.","volume":"321","author":"McPherson","year":"2000","journal-title":"BMJ"},{"issue":"12","key":"doi210052r3","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/ijd.2018.57.issue-12","article-title":"Pathogenesis and treatment options for chemotherapy-induced alopecia: a systematic review.","volume":"57","author":"Rubio-Gonzalez","year":"2018","journal-title":"Int J Dermatol"},{"issue":"40","key":"doi210052r4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta11400","article-title":"Taxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation.","volume":"11","author":"Ward","year":"2007","journal-title":"Health Technol Assess"},{"issue":"12","key":"doi210052r5","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1001\/jamadermatol.2018.3465","article-title":"Evaluation of prevention interventions for taxane-induced dermatologic adverse events: a systematic review.","volume":"154","author":"Marks","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"3","key":"doi210052r6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jaad.2013.10.034","article-title":"Clinical characteristics of chemotherapy-induced alopecia in childhood.","volume":"70","author":"Choi","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi210052r7","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/j.jaad.2011.02.026","article-title":"Chemotherapy-induced alopecia.","volume":"67","author":"Chon","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"doi210052r8","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jaad.2018.03.055","article-title":"Hair disorders in patients with cancer.","volume":"80","author":"Freites-Martinez","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"doi210052r9","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/dth.2011.24.issue-4","article-title":"Treatment of chemotherapy-induced alopecia.","volume":"24","author":"Yeager","year":"2011","journal-title":"Dermatol Ther"},{"issue":"5","key":"doi210052r10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/ced.12596","article-title":"Permanent chemotherapy-induced nonscarring alopecia and premature ovarian failure.","volume":"40","author":"Champagne","year":"2015","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"doi210052r11","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jaad.2016.12.027","article-title":"Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: clinicopathologic findings in a cohort of 10 patients.","volume":"76","author":"Fonia","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"doi210052r12","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1634\/theoncologist.2018-0184","article-title":"Permanent chemotherapy-induced alopecia in patients with breast cancer: a 3-year prospective cohort study.","volume":"24","author":"Kang","year":"2019","journal-title":"Oncologist"},{"issue":"3","key":"doi210052r13","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10549-017-4204-x","article-title":"Chemotherapy-induced irreversible alopecia in early breast cancer patients.","volume":"163","author":"Kim","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"doi210052r14","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1093\/annonc\/mds095","article-title":"Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil\/epirubicin\/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients.","volume":"23","author":"Kluger","year":"2012","journal-title":"Ann Oncol"},{"issue":"3","key":"doi210052r15","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10549-018-4855-2","article-title":"Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling.","volume":"171","author":"Mart\u00edn","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"doi210052r16","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jaad.2010.03.020","article-title":"Permanent chemotherapy-induced alopecia: a review.","volume":"64","author":"Palamaras","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"doi210052r17","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/bjd.2009.160.issue-4","article-title":"Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer.","volume":"160","author":"Prevezas","year":"2009","journal-title":"Br J Dermatol"},{"issue":"2","key":"doi210052r18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jaad.2009.06.063","article-title":"Permanent chemotherapy-induced alopecia: case report and review of the literature.","volume":"63","author":"Tallon","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"doi210052r19","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1111\/ajd.12350","article-title":"Treatment of permanent chemotherapy-induced alopecia with low dose oral minoxidil.","volume":"57","author":"Yang","year":"2016","journal-title":"Australas J Dermatol"},{"issue":"6","key":"doi210052r20","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1590\/abd1806-4841.20154013","article-title":"Clinical and histological study of permanent alopecia after bone marrow transplantation.","volume":"90","author":"Basilio","year":"2015","journal-title":"An Bras Dermatol"},{"issue":"2","key":"doi210052r21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0190-9622(03)00045-8","article-title":"The reliability of horizontally sectioned scalp biopsies in the diagnosis of chronic diffuse telogen hair loss in women.","volume":"51","author":"Sinclair","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"doi210052r22","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1097\/00007611-197511000-00009","article-title":"Male pattern baldness: classification and incidence.","volume":"68","author":"Norwood","year":"1975","journal-title":"South Med J"},{"issue":"5","key":"doi210052r23","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.jaad.2018.03.056","article-title":"Hair disorders in cancer survivors.","volume":"80","author":"Freites-Martinez","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"doi210052r24","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2353\/ajpath.2007.061164","article-title":"Dissecting the impact of chemotherapy on the human hair follicle: a pragmatic in vitro assay for studying the pathogenesis and potential management of hair follicle dystrophy.","volume":"171","author":"Bod\u00f3","year":"2007","journal-title":"Am J Pathol"},{"issue":"4","key":"doi210052r25","first-page":"719","article-title":"Chemotherapy-induced alopecia in mice: induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone.","volume":"144","author":"Paus","year":"1994","journal-title":"Am J Pathol"},{"issue":"2","key":"doi210052r26","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1016\/S1470-2045(12)70553-3","article-title":"Pathobiology of chemotherapy-induced hair loss.","volume":"14","author":"Paus","year":"2013","journal-title":"Lancet Oncol"},{"issue":"3","key":"doi210052r27","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/bjd.12716","article-title":"Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort study.","volume":"170","author":"Kanti","year":"2014","journal-title":"Br J Dermatol"},{"issue":"10","key":"doi210052r28","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911031","article-title":"CDK4\/6 inhibition mitigates stem cell damage in a novel model for taxane-induced alopecia.","volume":"11","author":"Purba","year":"2019","journal-title":"EMBO Mol Med"},{"issue":"9","key":"doi210052r29","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1001\/jamadermatol.2020.1867","article-title":"Association between ABCB1 genetic variants and persistent chemotherapy-induced alopecia in women with breast cancer.","volume":"156","author":"N\u00fa\u00f1ez-Torres","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"6","key":"doi210052r30","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1111\/bjd.2015.172.issue-6","article-title":"Differential expression and functionality of ATP-binding cassette transporters in the human hair follicle.","volume":"172","author":"Haslam","year":"2015","journal-title":"Br J Dermatol"},{"issue":"4","key":"doi210052r31","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/tpj.2014.81","article-title":"Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia.","volume":"15","author":"Gregers","year":"2015","journal-title":"Pharmacogenomics J"},{"issue":"6","key":"doi210052r32","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1001\/jamadermatol.2018.5071","article-title":"Assessment of quality of life and treatment outcomes of patients with persistent postchemotherapy alopecia.","volume":"155","author":"Freites-Martinez","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"4","key":"doi210052r33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/DAD.0b013e3181fcfc25","article-title":"Permanent alopecia after systemic chemotherapy: a clinicopathological study of 10 cases.","volume":"33","author":"Miteva","year":"2011","journal-title":"Am J Dermatopathol"},{"issue":"9","key":"doi210052r34","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1111\/exd.2018.27.issue-9","article-title":"A bald statement\u2014current approaches to manipulate miniaturisation focus only on promoting hair growth.","volume":"27","author":"Pantelireis","year":"2018","journal-title":"Exp Dermatol"},{"issue":"8","key":"doi210052r35","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1242\/dev.090662","article-title":"Dermal papilla cell number specifies hair size, shape and cycling and its reduction causes follicular decline.","volume":"140","author":"Chi","year":"2013","journal-title":"Development"},{"issue":"2","key":"doi210052r36","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1172\/JCI44478","article-title":"Bald scalp in men with androgenetic alopecia retains hair follicle stem cells but lacks CD200-rich and CD34-positive hair follicle progenitor cells.","volume":"121","author":"Garza","year":"2011","journal-title":"J Clin Invest"},{"issue":"12","key":"doi210052r37","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1016\/j.jprot.2011.09.019","article-title":"Impact of taxol on dermal papilla cells\u2014a proteomics and bioinformatics analysis.","volume":"74","author":"Chen","year":"2011","journal-title":"J Proteomics"},{"issue":"5","key":"doi210052r38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.molmed.2018.03.007","article-title":"Lichen planopilaris and frontal fibrosing alopecia as model epithelial stem cell diseases.","volume":"24","author":"Harries","year":"2018","journal-title":"Trends Mol Med"},{"issue":"2","key":"doi210052r39","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jaad.2019.04.054","article-title":"Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia.","volume":"81","author":"Jimenez-Cauhe","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi210052r40","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jaad.2019.08.060","article-title":"Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: a randomized clinical trial.","volume":"82","author":"Ramos","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"doi210052r41","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/ijd.v59.8","article-title":"Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review.","volume":"59","author":"Sharma","year":"2020","journal-title":"Int J Dermatol"},{"issue":"1","key":"doi210052r42","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/ijd.2018.57.issue-1","article-title":"Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone.","volume":"57","author":"Sinclair","year":"2018","journal-title":"Int J Dermatol"},{"issue":"6","key":"doi210052r43","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.jaad.2021.02.054","article-title":"Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients.","volume":"84","author":"Va\u00f1\u00f3-Galv\u00e1n","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"doi210052r44","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/exd.12945","article-title":"Hair regrowth in male and female pattern hair loss does not involve the conversion of vellus hair to terminal hair.","volume":"25","author":"Hugh Rushton","year":"2016","journal-title":"Exp Dermatol"},{"issue":"4","key":"doi210052r45","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.jaad.2020.05.081","article-title":"Spironolactone use does not increase the risk of female breast cancer recurrence: a retrospective analysis.","volume":"83","author":"Wei","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"doi210052r46","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/DSS.0000000000000755","article-title":"Bimatoprost 0.03% for the treatment of eyebrow hypotrichosis.","volume":"42","author":"Carruthers","year":"2016","journal-title":"Dermatol Surg"},{"issue":"10","key":"doi210052r47","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/jde.2012.39.issue-10","article-title":"Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study.","volume":"39","author":"Suwanchatchai","year":"2012","journal-title":"J Dermatol"},{"issue":"6","key":"doi210052r48","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1001\/jamadermatol.2018.0454","article-title":"Endocrine therapy\u2013induced alopecia in patients with breast cancer.","volume":"154","author":"Freites-Martinez","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"10","key":"doi210052r49","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1634\/theoncologist.2013-0193","article-title":"Alopecia with endocrine therapies in patients with cancer.","volume":"18","author":"Saggar","year":"2013","journal-title":"Oncologist"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2784689\/jamadermatology_bhoyrul_2021_oi_210052_1636039093.62076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T11:10:18Z","timestamp":1637147418000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2784689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2021.3676","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,1]]}}}